
Currently out of the existing stock ratings of Daniel Clark, 16 are a BUY (72.73%), 6 are a HOLD (27.27%).
Analyst Daniel Clark, currently employed at LEERINK, has had 40% of price targets met with an average potential upside of 9.4%, reached in 43 days on average.
Daniel Clark has documented 43 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VTRS, Viatris.
Analyst best performing recommendations are on IDXX (IDEXX LABORATORIES).
The best stock recommendation documented was for IDXX (IDEXX LABORATORIES) on 7/17/2025. The price target of $600 was fulfilled within 18 days with a profit of $81.29 (15.67%), with a performance score of 8.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2023
$32
$6.26 (24.32%)
$30
3 days ago
(19-Nov-2026)
Hold Since 29-Jan-2025
$25
$-0.74 (-2.87%)
$26
24 days ago
(29-Oct-2026)
15/20 (75%)
$1.76 (7.57%)
249
Buy Since 07-May-2026
$24
$-1.74 (-6.76%)
$30
1 months 2 days ago
(20-Oct-2026)
1/2 (50%)
$1.3 (5.73%)
13
Buy Since 21-Nov-2025
$30
$4.26 (16.55%)
$29
3 months 16 days ago
(06-Aug-2026)
0/3 (0%)
$5.8 (23.97%)
Buy Since 09-Dec-2024
$33
$7.26 (28.21%)
$30
3 months 16 days ago
(06-Aug-2026)
5/8 (62.5%)
$8.8 (36.36%)
115
Which stock is Daniel Clark most bullish on?
Which stock is Daniel Clark most reserved on?
What Year was the first public recommendation made by Daniel Clark?